delete National Health (Pharmaceutical Benefits) Amendment (2015 Measures No. 1) Regulation 2015
Amendment to the National Health (Pharmaceutical Benefits) Regulations governing Australia's Pharmaceutical Benefits Scheme (PBS), which subsidizes the cost of medicines for Australian residents. Registered 18 September 2015. The regulation typically addresses changes to listed medicines, pricing mechanisms, patient copayment structures, and pharmacy dispensing requirements under the PBS framework.
This amendment represents government-mandated pharmaceutical price controls and subsidy mechanisms that distort market signals. The PBS creates artificial demand suppression through subsidization while imposing fiscal burdens on taxpayers. Without access to the specific 2015 text, general PBS amendment patterns indicate compliance costs for pharmacies and manufacturers, bureaucratic delays in medicine listing processes, and market distortions that reduce pharmaceutical supply incentives. Such interventions violate principles of private property and voluntary exchange foundational to prosperity. The 2015 Measures No. 1 designation suggests typical budget-style amendments that layer additional regulatory burden without corresponding benefits.